Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Juvenile Psoriatic Arthritis (JPsA)”

9 trials

Showing 9 of 9 results

Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Large-scale testing (Phase 3)Study completedNCT03769168
What this trial is testing

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis Related Arthritis
Novartis Pharmaceuticals 55
Large-scale testing (Phase 3)Looking for participantsNCT06100744
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Who this might be right for
Juvenile Psoriatic Arthritis
AbbVie 40
Not applicableLooking for participantsNCT05754710
What this trial is testing

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

Who this might be right for
Psoriatic Arthritis, JuvenilePolyarticular Juvenile Idiopathic Arthritis
Pfizer 10
Early research (Phase 1)Looking for participantsNCT06751238
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

Who this might be right for
Juvenile Psoriatic Arthritis
Novartis Pharmaceuticals 20
Not applicableNot Yet RecruitingNCT07190053
What this trial is testing

Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

Who this might be right for
Enthesitis-related Arthritis (ERA)Juvenile Psoriatic Arthritis (JPsA)
Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT03031782
What this trial is testing

Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis-related Arthritis
Novartis Pharmaceuticals 86
Large-scale testing (Phase 3)Study completedNCT03773978
What this trial is testing

Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 220
Large-scale testing (Phase 3)Looking for participantsNCT06869551
What this trial is testing

Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Who this might be right for
Juvenile Psoriatic Arthritis
Bristol-Myers Squibb 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation